If you have questions about insurance coverage for compounded semaglutide, consider reviewing your plans coverage literature or calling the company directly
Reddy's Laboratories submitted a generic semaglutide application to Health Canada for review in early 2024, making it one of the first companies to seek approval for generic versions of the medication in Canada
Pro-inflammatory cytokines after an episode of acute pancreatitis: associations with fasting gut hormone profile
People living with obesity need treatment options that meet them where they are and for many, a once-daily pill that can be taken with no food or water restrictions can offer them greater flexibility in how they approach their treatment, said Deborah Horn, DO, director of the Center for Obesity Medicine at McGovern Medical School at UTHealth Houston, in a press release
Diabetes is a high risk factor for endometrial cancer, but the same pathological basis is insulin resistance